NCT00164008View on ClinicalTrials.gov

Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
OsteopeniaComplications of Heart-lung TransplantOther Complications of Lung Transplant
Interventions
DRUG

zoledronic acid vs pamidronate

Sponsors

Lead Sponsor

Bayside Health

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Bayside Health

OTHER_GOV

NCT00164008 - Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention | Biotech Hunter | Biotech Hunter